Clinical, medical, and economical benefits of Point-of-care diagnosis of acute coronary syndrome, thromboembolic events, and heart failure in primary care.

Not Applicable

• Conditions: I20.0; I21; I22; I50; I26; I80.2; Unstable angina; Acute myocardial infarction; Subsequent myocardial infarction; Heart failure

• Registration Number: DRKS00000709
• Lead Sponsor: DirectorInstitute of Pharmaceutical Medicine/European Center of Pharmaceutical MedicineUniversity of Basel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2008-10-02
• Study Start: 2011-02-14
• Results First Posted: 2011-03-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 520

Inclusion Criteria

Adult patients (> 18 years) presenting with potentially cardiovascular chest pain or symptoms

Exclusion Criteria

Refusal of consent, presentation >5 days after symptom onset, recent anticoagulant treatment, severe renal dysfunction and cancer therapy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnostic accuracy: working diagnosis vs. confirmed/Follow-up diagnosis (about 3 weeks after working diagnosis)

Secondary Outcome Measures

Name	Time	Method
Resource utilisation (consultation, transport, hospitalisation) and workdays lost between baseline and follow-up